Bluejay Diagnostics, Inc. (BJDX) Operating cash flow 2020–2025
Bluejay Diagnostics, Inc. (BJDX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.1MFY2025 · since FY2020: -$508,710 → -$6.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.1M | +22.6% |
| FY2024 | -$7.8M | +5.9% |
| FY2023 | -$8.3M | -7.4% |
| FY2022 | -$7.7M | -77.3% |
| FY2021 | -$4.4M | -758.4% |
| FY2020 | -$508,710 | — |
Source: SEC XBRL filings · For reference only · Not investment advice